Related Experiment Video
Updated: Aug 22, 2026

Through-the-Wall Blood Sampling Method to Minimize Sleep Disruption in Clinical Settings
Published on: June 13, 2025
Systemic growth hormone corrects sleep disturbance in Smith-Magenis syndrome
Masahiro Itoh1, Masaharu Hayashi, Takeshi Hasegawa
1Department of Pediatrics, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan.
Abstract:
Smith-Magenis syndrome (SMS) is a multiple congenital anomaly syndrome characterized by an interstitial deletion of chromosome 17p11.2. Sleep problems such as nocturnal awakening and abnormality in the percentage of rapid eye movement (REM) sleep are frequently observed in patients with SMS, and several medications have been administered to improve the sleep disorders. Here we present a female case of SMS showing early waking and reduction of REM sleep, which were corrected by human growth hormone (GH) replacement for her dwarfism. Also, we report changes in the sleep-wakefulness circadian rhythm and polysomnographical data before and after the start of human GH replacement. It is speculated that GH deficiency could be involved in sleep disturbance in SMS.
Related Concept Videos
Management of Insomnia
Hypoglycemia and Glucagon
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
Circadian Rhythms and Gene Regulation
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cellular Adaptation II: Hypertrophy

